| EMA number | EMEA/H/C/003953 |
| ATC code | R03AK07 |
| Authorisation | 19 November 2014 |
| Withdrawn | 16 December 2016 |
| Revision | 1 |
Budesonide/Formoterol Teva Pharma B.V. is indicated in adults 18 years of age and older only. AsthmaBudesonide/Formoterol Teva Pharma B.V. is indicated in the regular treatment of asthma, where use of a combination (inhaled corticosteroid and long-acting ?2 adrenoceptor agonist) is appropriate: or in patients not adequately controlled with inhaled corticosteroids and “as needed” inhaled short-acting ?2 adrenoceptor agonists. in patients already adequately controlled on both inhaled corticosteroids and long-acting ?2 adrenoceptor agonists.